These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 12389487
21. Molecular characterisation and clonal analysis of group A streptococci causing pharyngitis among paediatric patients in Palermo, Italy. Lorino G, Gherardi G, Angeletti S, De Cesaris M, Graziano N, Maringhini S, Merlino F, Di Bernardo F, Dicuonzo G. Clin Microbiol Infect; 2006 Feb; 12(2):189-92. PubMed ID: 16441461 [Abstract] [Full Text] [Related]
27. Increase of emm1 isolates among group A Streptococcus strains causing scarlet fever in Shanghai, China. Chen M, Cai J, Davies MR, Li Y, Zhang C, Yao W, Kong D, Pan H, Zhang X, Zeng M, Chen M. Int J Infect Dis; 2020 Sep; 98():305-314. PubMed ID: 32562850 [Abstract] [Full Text] [Related]
28. Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996-2002: results from a voluntary laboratory surveillance system. Wahl RU, Lütticken R, Stanzel S, van der Linden M, Reinert RR. Clin Microbiol Infect; 2007 Dec; 13(12):1173-8. PubMed ID: 17850344 [Abstract] [Full Text] [Related]
32. Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics. Orscheln RC, Johnson DR, Olson SM, Presti RM, Martin JM, Kaplan EL, Storch GA. J Infect Dis; 2005 Apr 15; 191(8):1272-9. PubMed ID: 15776373 [Abstract] [Full Text] [Related]
33. Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections. Ikebe T, Hirasawa K, Suzuki R, Isobe J, Tanaka D, Katsukawa C, Kawahara R, Tomita M, Ogata K, Endoh M, Okuno R, Watanabe H. Antimicrob Agents Chemother; 2005 Feb 15; 49(2):788-90. PubMed ID: 15673769 [Abstract] [Full Text] [Related]
34. Identification of an erm(T) gene in strains of inducibly clindamycin-resistant group B Streptococcus. Dipersio LP, Dipersio JR. Diagn Microbiol Infect Dis; 2007 Feb 15; 57(2):189-93. PubMed ID: 16989973 [Abstract] [Full Text] [Related]
35. Molecular epidemiologic analysis of the type A streptococcal exotoxin (erythrogenic toxin) gene (speA) in clinical Streptococcus pyogenes strains. Yu CE, Ferretti JJ. Infect Immun; 1989 Dec 15; 57(12):3715-9. PubMed ID: 2553612 [Abstract] [Full Text] [Related]
36. Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains. Woodbury RL, Klammer KA, Xiong Y, Bailiff T, Glennen A, Bartkus JM, Lynfield R, Van Beneden C, Beall BW, Active Bacterial Core Surveillance Team. Antimicrob Agents Chemother; 2008 Mar 15; 52(3):1140-3. PubMed ID: 18180360 [Abstract] [Full Text] [Related]
37. Erythrogenic toxin type A (ETA): epidemiological analysis of gene distribution and protein formation in clinical Streptococcus pyogenes strains causing scarlet fever and the streptococcal toxic shock-like syndrome (TSLS). Reichardt W, Müller-Alouf H, Köhler W. Zentralbl Bakteriol; 1993 Jun 15; 279(2):283-93. PubMed ID: 8219499 [Abstract] [Full Text] [Related]
38. Temporal variation in bacterial disease frequency: molecular population genetic analysis of scarlet fever epidemics in Ottawa and in eastern Germany. Musser JM, Nelson K, Selander RK, Gerlach D, Huang JC, Kapur V, Kanjilal S. J Infect Dis; 1993 Mar 15; 167(3):759-62. PubMed ID: 8440944 [Abstract] [Full Text] [Related]
39. [An outbreak of Streptococcus pyogenes infections in institutions for the mentally retarded in Greater Copenhagen 1995]. Kristensen B, Egelund B, Meyer M, Henrichsen J, Jepsen OB, Sievers CJ, Lundstedt C. Ugeskr Laeger; 1996 Mar 18; 158(12):1679-82. PubMed ID: 8644412 [Abstract] [Full Text] [Related]
40. [Investigation of erythromycin resistance and resistance phenotypes in group A beta hemolytic streptococci]. Kaya EG, Yücel M, Karakoç AE. Mikrobiyol Bul; 2006 Jul 18; 40(3):161-8. PubMed ID: 17001844 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]